CLNN affiliate files Form 144 to sell 477,000 shares

CLNN affiliate submitted a Form 144 notice to sell 477,000 shares of Common Stock.

Rhea-AI Filing Summary

CLNN affiliate submitted a Form 144 notice to sell 477,000 shares of Common Stock.

The filing lists multiple recent open‑market dispositions by Symbiosis II LLC from 12/22/2025 through 02/03/2026, with per‑trade share counts and gross proceeds reported for each trade.

Insights

Securities Counsel

Form 144 notice records a proposed affiliate resale and lists recent open‑market trades by a single holder.

The filing shows a proposed sale of 477,000 shares of Common Stock under Form 144 procedures. It lists many executed open‑market transactions by Symbiosis II LLC, each with trade date, share count, and gross proceeds.

Cash‑flow treatment and exact distribution method beyond "open market" are as reported in the excerpt; timing and any conditions tied to the sale are those stated in the filing text.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CLNN's Form 144 disclose?

It discloses a proposed resale of 477,000 shares of Common Stock under Form 144 procedures. The filing also itemizes multiple open‑market trades by Symbiosis II LLC with dates and gross proceeds from 12/22/2025 to 02/03/2026.

Who is the seller listed in the CLNN filing?

The excerpt lists Symbiosis II LLC as a selling party making open‑market dispositions. The filing shows numerous trades by that entity, each entry including trade date, shares sold, and reported gross proceeds in dollars.

How many shares are shown as proposed for sale in CLNN's Form 144?

The filing shows a proposed sale amount of 477,000 shares of Common Stock. The notice also provides a timeline of executed trades by Symbiosis II LLC with per‑trade share counts and dollar proceeds.

Do the Form 144 entries show recent transactions by the seller?

Yes. The filing lists multiple recent open‑market transactions by Symbiosis II LLC, for example 32,705 shares on 01/12/2026 and 26,105 shares on 01/13/2026, each with gross proceeds reported.

Were the sales executed on an exchange?

The excerpt indicates trades were open‑market transactions and references Nasdaq in the securities header. Individual trade rows list dates, share counts, and dollar proceeds for each open‑market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002006045
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clene Inc
SEC File Number	001-39834
Address of Issuer	6550 SOUTH MILLROCK DRIVE SUITE G50 SALT LAKE CITY UTAH 84121
Phone	8016769695
Name of Person for Whose Account the Securities are To Be Sold	Symbiosis II LLC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Board Member

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California St Ste 1800 San Francisco CA 94104	82212	477000	11778307	03/24/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/20/2023	Open Market Purchase	Issuer			125706	06/20/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/22/2025	4367	28547.39
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/23/2025	6831	42848.38
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/24/2025	1490	9336.79
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/26/2025	3350	21174.24
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/29/2025	8096	48159.37
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/30/2025	4138	24966.83
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/31/2025	13095	76054.07
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/02/2026	4015	22996.19
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/05/2026	5869	34472.7
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/06/2026	3111	18791.18
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/07/2026	3938	24771.49
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/08/2026	3195	19448.5
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/09/2026	9075	56900.82
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/12/2026	32705	179867.17
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/13/2026	26105	127631.6
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/14/2026	19621	100496.05
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/15/2026	12563	64040.34
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/16/2026	7923	40626.13
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/20/2026	12432	59731.78
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/21/2026	12119	61227.75
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/22/2026	12665	67323.13
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/23/2026	5556	29256.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/26/2026	6418	32186.97
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/27/2026	4139	21016.06
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/28/2026	8717	42789.36
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	3810	15843.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	11474	50113.36
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/30/2026	5686	23493.07
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/02/2026	2050	8262.02
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/02/2026	1750	7102.19
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/03/2026	5559	22818.28

144: Remarks and Signature

Remarks
Date of Notice	03/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	John Cardente
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)